News

Viewing Page 1 of 1 | Showing Results 1 - 2 of 2

Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

Immunotherapy and Providence Cancer Center featured in Portland Business Journal

July 11, 2014
In the cover story of the July 11, 2014 issue, the Portland Business Journal explores the current state of cancer treatments and the role Portland researchers are playing in new research.
Viewing Page 1 of 1 | Showing Results 1 - 2 of 2